T. Taş Et Al. , "In Vitro Evaluation of Novel Hsp90 Inhibitors Determined with In Silico Drug Repurposing Approach," 5th International Eurasian Conference on Biological and Chemical Sciences , Ankara, Turkey, pp.1723, 2022
Taş, T. Et Al. 2022. In Vitro Evaluation of Novel Hsp90 Inhibitors Determined with In Silico Drug Repurposing Approach. 5th International Eurasian Conference on Biological and Chemical Sciences , (Ankara, Turkey), 1723.
Taş, T., Özpolat, Ö. F., & Kılıç, D., (2022). In Vitro Evaluation of Novel Hsp90 Inhibitors Determined with In Silico Drug Repurposing Approach . 5th International Eurasian Conference on Biological and Chemical Sciences (pp.1723). Ankara, Turkey
Taş, Tuğba, Özgür Fırat ÖZPOLAT, And Deryanur KILIÇ. "In Vitro Evaluation of Novel Hsp90 Inhibitors Determined with In Silico Drug Repurposing Approach," 5th International Eurasian Conference on Biological and Chemical Sciences, Ankara, Turkey, 2022
Taş, Tuğba Et Al. "In Vitro Evaluation of Novel Hsp90 Inhibitors Determined with In Silico Drug Repurposing Approach." 5th International Eurasian Conference on Biological and Chemical Sciences , Ankara, Turkey, pp.1723, 2022
Taş, T. Özpolat, Ö. F. And Kılıç, D. (2022) . "In Vitro Evaluation of Novel Hsp90 Inhibitors Determined with In Silico Drug Repurposing Approach." 5th International Eurasian Conference on Biological and Chemical Sciences , Ankara, Turkey, p.1723.
@conferencepaper{conferencepaper, author={Tuğba Taş Et Al. }, title={In Vitro Evaluation of Novel Hsp90 Inhibitors Determined with In Silico Drug Repurposing Approach}, congress name={5th International Eurasian Conference on Biological and Chemical Sciences}, city={Ankara}, country={Turkey}, year={2022}, pages={1723} }